“…This time frame was not acceptable in urgent cases of symptomatic or ruptured aneurysms. The necessity for off-the-shelf mbSG led to the production of the Zenith t-Branch device (Cook Medical, Bloomington, IN, USA), which according to studies, could be a treatment solution for over twothirds of patients requiring a stent graft [2,3]. However, target artery cannulation and connection with the bridging stents can be challenging in unfavourable anatomy.…”